By Catherine Eckford (European Pharmaceutical Review)2024-01-26T13:31:24
UK scientists have unlocked the potential of bioengineering vaccine adjuvants, based on a study of the molecule QS-21.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-27T15:37:00
Sponsored by IMA Pharma
2025-11-20T15:00:00
Sponsored by Rapid Micro Biosystems
2025-07-16T11:00:00
Sponsored by USP
2025-06-11T13:00:00
Sponsored by Rapid Micro Biosystems
2025-10-22T14:00:00
Sponsored by Bruker
2026-02-25T15:00:00
Sponsored by Particle Measuring Systems
Site powered by Webvision Cloud